OARtrac® provides gold standard accuracy, real-time pinpoint measurement, and dedicated intracavitary delivery devices to measure physical dose during radiation treatment.
The system provides critical dose feedback which helps facilitate adaptive radiotherapy with the goal to reduce side effects and better clinical outcomes.
RadiaDyne’s Market Leading Endorectal Balloon Highlighted in Key Clinical Study for Post-Prostatectomy Cancer Patients Treated with Protons
The RadiaDyne Endorectal Balloon was used to immobilize the prostatic fossa, provide reproducible anatomy, and spare the posterior rectal wall, which was critical to reduce dose uncertainties. Patient outcomes showed favorable acute and late GU and GI toxicities.